Thread: Frustrated on priority with Tasigna/nilotinib
View Single Post
Old 10-31-2016, 09:21 PM
sim00's Avatar
sim00 sim00 is offline
Member
  
Join Date: Jun 2011
Location: Italy
Posts: 192
10 yr Member
sim00 sim00 is offline
Member
sim00's Avatar
 
Join Date: Jun 2011
Location: Italy
Posts: 192
10 yr Member
Default
Quote:
Originally Posted by lurkingforacure View Post
Has anyone else noticed how slow the Tagisna trial process for PD is moving but how fast it is moving for Alz? This is so frustrating! Moussa's work at Georgetown was done on PD, he's talked about a bigger trial for PD, Fox has talked about a Tagisna trial for PD, as have others...but these trials have gotten pushed back for over a year. Even now I cannot find where the trial sites will be, when recruitment will begin, what the criteria will be, nothing.

Meanwhile, the FDA has apparently approved a clinical trial of Tasigna for Alz. and the trial is schedule to begin THIS YEAR:

Alzheimer's Study Funded by ADDF to Test Cancer Treatment in Patients

What's up with this?
Hi lurking,
this is an interesting article about that:
α-Synuclein binds to TOM2 and inhibits mitochondrial protein import in Parkinson’s disease | Science Translational Medicine
__________________
Sim00

Born in 1969, diagnosed PD in 2007, first symptoms 2004. DBS in July 2016.
sim00 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (11-01-2016), lurkingforacure (11-02-2016), olsen (11-01-2016)